http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6d4fb4cf422f6139ca70f2a0ffdb0569
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Yang |
| name | Dajun Yang |
| given-name | Dajun |
| organization-name | Laboratory of Medicinal Chemistry, Center for Cancer Research, National Cancer Institute, National Institutes of Health, NCIFrederick, P.O. Box B, Building 376 Boyles Street, Frederick, Maryland 21702, and Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan 48109 Comprehensive Cancer Center and Departments of Internal Medicine, Pharmacology and Medicinal Chemistry, University of Michigan, 1500 E. Medical Center Drive, Ann Arbor, Michigan 48109, Ascenta Therapeutics, Inc., 101 Lindenwood Drive, Suite 405, Malvern, Pennsylvania 19355 Laboratory of Medicinal Chemistry, Division of Basic Sciences, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, and Lombardi Cancer Center, Georgetown University Medical Center, Washington, DC Authors' Affiliations: 1State Key Laboratory of Oncology in Southern China, Sun Yat-Sen University Cancer Center and 2The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou; and 3Ascentage Pharma Group Corp. Limited, Jiangsu, China; Authors' Affiliations: 1State Key Laboratory of Oncology in Southern China, Sun Yat-Sen University Cancer Center and 2The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou; and 3Ascentage Pharma Group Corp. Limited, Jiangsu, China Ascenta Therapeutics, 101 Lindenwood Drive, Malvern, Pennsylvania 19355, United States State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China; Department of Experimental Research, Sun Yat-Sen University Cancer Center, Guangzhou 510060, China Jiangsu Ascentage Biomed Development Inc., China Medical City, Taizhou, Jiangsu 225300, China; Suzhou Ascentage Pharma Inc., Suzhou, Jiangsu 215123, China; Department of Experimental Research, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, 651 Dongfeng Road East, Guangzhou, China Comprehensive Cancer Center and Departments of Internal Medicine, Pharmacology and Medicinal Chemistry, and Life Sciences Institute, University of Michigan, 1500 E. Medical Center Drive, Ann Arbor, Michigan 48109, Laboratory of Medicinal Chemistry, National Cancer Institute-Frederick, National Institutes of Health, Frederick, Maryland 21702, and Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, D.C. 20057 Structural Biology and Cancer Drug Discovery Program, Lombardi Cancer Center and Department of Oncology, Georgetown University Medical Center, 3970 Reservoir Road, Washington, D.C. 20007, and Laboratory of Medicinal Chemistry, National Cancer Institute, FCRDC, Building 376, Room 207, Fredrick, Maryland 21702 Ascentage Pharma (Suzhou) Co., Ltd., Suzhou, China; State Key Laboratory of Oncology, South China Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China Laboratory of Medicinal Chemistry, CCR, National Cancer Institute, National Institutes of Health, Frederick, Maryland 21702, Protein Chemistry Laboratory, SAICFrederick, Frederick, Maryland 21702, and University of Michigan Medical School, Ann Arbor, Michigan 48109 Laboratory of Medicinal Chemistry, CCR, National Cancer Institute, National Institutes of Health, Frederick, Maryland 21702, University of Michigan Medical School, Ann Arbor, Michigan 48109, Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215, and Protein Chemistry Laboratory, SAICFrederick, Frederick, Maryland 21702 Ascenta Therapeutics, Malvern, PA; Ascenta Therapeutics Inc.,101 Lindenwood Drive, Malvern, Pennsylvania 19355 5Ascenta Therapeutics, Inc., San Diego, California Ascentage Pharma (Jiangsu), Medical City Avenue, QB3 Building First Floor, Taizhou, Jiangsu Province 225300, China Laboratory of Medicinal Chemistry, Center for Cancer Research, National Cancer InstituteFrederick, National Institutes of Health, Frederick, Maryland 21702, and Department of Hematology/Oncology, University of Michigan Medical School, Ann Arbor, Michigan 48109 2Division of Hematology and Oncology, University of Michigan, Ann Arbor, Michigan; and Department of Experimental Research, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou 510060, China; Suzhou Ascentage Pharma Inc., Jiangsu 215123, China Laboratory of Medicinal Chemistry, National Cancer Institute, National Institutes of Health, Frederick, Maryland 21702, and School of Medicine, University of Michigan, Ann Arbor, Michigan 48109 Ascenta Therapeutics Inc, Malvern, PA; and Ascenta Therapeutics, Inc., Malvern, PA 19355 Yasheng Biomedical Inc., Halei Road, Zhangjiang Hi-Tech Park, Pudong, Shanghai 201203, China; Ascentage Pharma (Jiangsu), Medical City Avenue, QB3 Building First Floor, Taizhou, Jiangsu Province, China University of Michigan Comprehensive Cancer Center, Departments of Internal Medicine and Medicinal Chemistry, University of Michigan, Ann Arbor, Michigan 48109-0934, Lombardi Cancer Center, Georgetown University Medical Center, Washington, DC 20057, and Laboratory of Medicinal Chemistry, National Cancer Institute, FCRDC, Frederick, Maryland 21702-1201 Department of Experimental Research, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China 1Department of Internal Medicine, Division of Hematology and Oncology and |
Incoming Links
Total number of triples: 119.